Skip to Content

'
Bin Wang, Ph.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Assistant Professor, The University of Texas Graduate School of Biomedical Sciences, Houston, TX

Research Interests

  • DNA damage response
  • Genomic instability and Cancer
  • BRCA1 signaling
  • Ubiquitin signaling

Defects in the ability of cells to properly respond to and repair DNA damage result in genomic instability and underlie many forms of cancer. The goal of our research is to understand how cells respond to DNA damage and safeguard the integrity of the genome.

Cells have evolved a complex sensory network called the DNA damage response (DDR) to respond to genotoxic stress. The DDR coordinates cell cycle regulation, DNA repair, chromatin reorganization and transcription in response to damage. Once DNA damage is sensed, a phosphorylation signaling cascade is initiated by the central DNA damage kinases, ATM and ATR. Recently, a DNA damage induced ubiquitin signaling pathway has also emerged that works together with phosphorylation-dependent signaling to recruit essential repair factors to the sites of DNA damage. Damage-induced ATM/ATR phosphorylation on S139 of histone H2AX directly recruits MDC1 through MDC1’s BRCT domains. MDC1 itself is a substrate of ATM/ATR, and its phosphorylation leads to the recruitment of a ubiquitin E2/E3 ligase RNF8/UBC13 to damage sites. We are seeking to identify additional players in this signaling cascade and investigate the role of each player in the DNA damage repair and signaling, as well as its role in cancer progression.

The RNF8/Ubc13-dependent ubiquitination on the damaged chromatin creates docking sites for BRCA1 complexes. The BRCA1 tumor suppressor is associated with hereditary breast and ovarian cancer and plays critical roles in DNA repair, cell cycle checkpoint control and maintenance of genomic stability. BRCA1 contains two C-terminal BRCT repeats and a N-terminal RING domain that binds BARD1 forming an E3 ubiqutin ligase. Recently we have identified a novel BRCA1 associated protein complex, the Rap80/Abraxas/BRCA1 complex (BRCA1-A complex). In this complex, Abraxas contains a phosphorylated SPxF motif at its C-terminus that associates with the BRCT domain of BRCA1. The BRCA1-A complex also contains a deubiquitination enzyme BRCC36. We are currently investigating how the BRCA1-A complex is involved in BRAC1’s function in breast tumor suppression.

In summary, we are interested in using various biochemical and genetic approaches, such as gene knockouts, mass spectrometry and genetic screens using siRNA libraries, to identify important players in the DNA damage response and define the roles of these proteins in maintaining genomic stability and tumor suppression.

View a compelte list of Dr. Wang's publications.

Office Address

The University of Texas MD Anderson Cancer Center
Department of Genetics Unit 1010
1515 Holcombe Blvd
Houston, TX 77030
Room Number: BSRB S13.8116A
Phone: 713 834-6365
Email: bwang3@mdanderson.org

Education & Training

Degree-Granting Education

2000 Baylor College of Medicine, Houston, TX, PHD, Biochemistry and Molecular Biology

Postgraduate Training

10/2003-8/2008 Postdoctoral Fellow, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, Dr. Stephen J. Elledge
10/2000-10/2003 Postdoctoral Fellow, Baylor College of Medicine, Houston, TX, Dr. Stephen J. Elledge

Selected Publications

Peer-Reviewed Original Research Articles

1. Hu X, Kim JA, Castillo A, Huang M, Liu J, Wang B. NBA1/Merit40 and BRE interaction is required for the integrity of two distinct deubiquitinating enzyme BRCC36 containing complexes. J Biol Chem 286(13):11734-45, 4/2011. e-Pub 1/2011. PMCID: PMC3064225.
2. Wang B, Hurov K, Hofmann K, Elledge SJ. NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control. Genes Dev 23(6):729-39, 3/2009. PMCID: PMC2661606.
3. Xiao A, Li H, Schecter D, Ahn SH, Fabrizio LA, Erdjument-Bromage H, Ishibe-Murakami S, Wang B, Tempst P, Hofmann K, Patel DJ, Elledge SJ, Allis CD. WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity. Nature 457(7225):57-62, 1/2009. e-Pub 12/2008. PMCID: PMC2854499.
4. Wang B, Elledge SJ. Ubc 13/Rnf8 ubiquitin ligase controls foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc Natl Acad Sci U S A 104(52):20759-63, 12/2007. e-Pub 12/2007. PMCID: PMC2410075.
5. Wang B, Matsuoka S, Ballif BA, Zhang D, Smogorzewska A, Gygi S, Elledge SJ. Abraxas and Rap80 form a BRCA1 protein complex required for the DNA damage response. Science 316(5828):1194-8, 2007. PMID: 17525340.
6. Adams MM, Wang B, Xia Z, Morales JC, Lu X, Donehower LA, Bochar DA, Elledge SJ, Carpenter PB. 53BP1 oligomerization is independent of its methylation by PRMT1. Cell Cycle 4(12):1854-61, 2005. PMID: 16294047.
7. Morales JC, Xia Z, Lu T, Aldrich MB, Wang B, Rosales C, Kellems RE, Hittelman WN, Elledge SJ, Carpenter PB. Role for the BRCA1 C-terminal repeats (BRCT) protein 53BP1 in maintaining genomic stability. J Biol Chem 278(17):14971-7, 4/2003. PMID: 12578828.
8. Stewart G, Wang B, Bignell CR, Taylor AM, Elledge SJ. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421(6926):961-6, 2/2003. PMID: 12607005.
9. Wang B, Matsuoka S, Carpenter PB, Elledge SJ. 53BP1 a mediator of the DNA damage checkpoint. Science 298(5597):1435-8, 11/2002. PMID: 12364621.
10. Wang B, Kuspa A. CulB, a putative ubiquitin ligase subunit, regulates prestalk cell differentiation and morphogenesis in Dictyostelium spp. Eukaryotic Cell 1(1):126-36, 2002. PMCID: PMC118045.

Last updated: 11/18/2013